Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Tevogen Inc.Bullish
Tevogen Inc. has regained compliance with the Nasdaq Global Market's minimum market value of listed securities requirement of $50 million. With this development, all previously disclosed Nasdaq compliance matters regarding listing requirements are now closed.…more
Tevogen Inc.
According to the Schedule 13D/A filing submitted by major shareholder Ryan H. Saadi, changes in the beneficial ownership of Tevogen Inc. have been reported. This filing formalizes the shift in the company's equity structure, and investors should monitor how these changes in the shareholder's position may impact future corporate governance and stock performance.…more
Tevogen Inc.
Kirti Desai, a major shareholder of Tevogen Inc., has updated their beneficial ownership status through a Schedule 13D/A filing. This filing serves as an official report regarding changes in the shareholder's equity position.…more
16 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare…more
Tevogen has signed a non-binding letter of intent to evaluate the potential acquisition of HRK Healthcare to expand its service capabilities. The transaction remains in the preliminary stage, and there is no guarantee that a definitive agreement will be reached.…more
●●●●●●●● ●●●●● ●●●●●●
Tevogen announced that it has received confirmation from Nasdaq regarding its compliance with the $50 million minimum market value requirement. This development resolves the company's previous listing deficiency status.…more
●●●●●●●● ●●●●● ●●●●●●
Tevogen has regained compliance with Nasdaq's minimum market value requirements for continued listing. All previously disclosed Nasdaq compliance matters regarding the company are now officially closed.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.